Xvivo Perfusion AB (XVIVO)
Stockholm Exchange · Sweden · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 232.40 |
|---|---|
| 52-week range | 160.10 – 314.80 |
| Return, 1 month / 3 months | −5.3% / −3.7% |
| Return, 1 year / 3 years | +44.5% / −9.6% |
| Trend | Below its 200-day average |
| RSI (14) | 51 |
| Volatility (1 year) | 47.9% |
| Worst drawdown (1 year) | -33.3% |
| Average daily value traded | 18.30M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Xvivo Perfusion is a Swedish medical technology company based in Gothenburg that develops equipment and solutions for preserving donor organs outside the body before transplantation. Its systems keep lungs, kidneys and livers functioning and assessable during transport and storage, helping transplant teams judge whether an organ is suitable. Customers are hospitals and transplant centres that use the company's perfusion machines and related products in clinical practice.
On this site Xvivo Perfusion AB appears as a stock on the Stockholm Exchange (Sweden), code XVIVO, with prices in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Xvivo Perfusion AB (XVIVO) trades on the Stockholm Exchange in Sweden. It last closed at SEK 232.40 on 19 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 299 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 44.5% and over the last three months it fell 3.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -4.5% | ||
| From 52-week high | -24.8% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.7% | ||
| 6-month return | -23.9% | ||
| 12-month return, skipping the last month | 52.6% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 47.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.3% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 18.30M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +10.6% |
|---|---|
| 1 month | −5.3% |
| 3 months | −3.7% |
| 6 months | −23.9% |
| 1 year | +44.5% |
| 3 years | −9.6% |
| 5 years | – |
Signals
| 50-day / 200-day average | 251.66 / 243.32 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.60 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.